메뉴 건너뛰기




Volumn 29, Issue 6, 2001, Pages 380-385

Risperidone in the treatment of psychotic patients with opiate abuse and dependence;Risperidona en el tratamiento de pacientes psicóticos con abuso y dependencia de opiáceos

Author keywords

Opiate abuse; Psychotic disorder; Risperidone; Treatment

Indexed keywords

NEUROLEPTIC AGENT; RISPERIDONE;

EID: 0035542905     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (8)

References (21)
  • 3
    • 0034039784 scopus 로고    scopus 로고
    • Addiction and schizophrenia
    • Batel P. Addiction and schizophrenia. Eur Psychiatry 2000;15:115-22.
    • (2000) Eur Psychiatry , vol.15 , pp. 115-122
    • Batel, P.1
  • 5
    • 0034713218 scopus 로고    scopus 로고
    • Sex differences in illness presentation, course and level of functioning in substance-abusing schizophrenia patients
    • Gearon JS, Bellack AS. Sex differences in illness presentation, course and level of functioning in substance-abusing schizophrenia patients. Schizophr Res 2000;43:65-70.
    • (2000) Schizophr Res , vol.43 , pp. 65-70
    • Gearon, J.S.1    Bellack, A.S.2
  • 7
    • 0031774802 scopus 로고    scopus 로고
    • Prevalence, severity of substance use disorders and outset of psychosis in first-admission psychotic patients
    • Rabinowitz J, Bromet EJ, Lavalle J, Carsson G, Kovasznay B, Schwartz JE. Prevalence, severity of substance use disorders and outset of psychosis in first-admission psychotic patients. Psychol Med 1998;15:1411-9.
    • (1998) Psychol Med , vol.15 , pp. 1411-1419
    • Rabinowitz, J.1    Bromet, E.J.2    Lavalle, J.3    Carsson, G.4    Kovasznay, B.5    Schwartz, J.E.6
  • 8
    • 0034007607 scopus 로고    scopus 로고
    • Which temperamental characteristics are associated with substance abuse use in subjects with psychotic and mood disorders?
    • Liraud F, Verdoux H. Which temperamental characteristics are associated with substance abuse use in subjects with psychotic and mood disorders? Psychiatry Res 2000;93:63-72.
    • (2000) Psychiatry Res , vol.93 , pp. 63-72
    • Liraud, F.1    Verdoux, H.2
  • 11
    • 7144222759 scopus 로고    scopus 로고
    • Therapeutic equivalence of risperidone given once daily and twice daily in patients with schizophrenia
    • Nair NPV, and the Risperidone Study Group. Therapeutic equivalence of risperidone given once daily and twice daily in patients with schizophrenia. J Clin Psychopharmacol 1998;18:103-10.
    • (1998) J Clin Psychopharmacol , vol.18 , pp. 103-110
  • 12
    • 0027475985 scopus 로고
    • A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
    • Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, et al. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 1993;13:25-40.
    • (1993) J Clin Psychopharmacol , vol.13 , pp. 25-40
    • Chouinard, G.1    Jones, B.2    Remington, G.3    Bloom, D.4    Addington, D.5    MacEwan, G.W.6
  • 13
    • 0028342655 scopus 로고
    • Risperidone in the treatment of schizophrenia
    • Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994;151:825-35.
    • (1994) Am J Psychiatry , vol.151 , pp. 825-835
    • Marder, S.R.1    Meibach, R.C.2
  • 14
    • 0028865612 scopus 로고
    • Risperidone in the treatment of patients with chronic schizophrenia: A multi-national, multicentre, double-blind, parallel-group study versus haloperidol
    • Peuskens J. on behalf of the Risperidone Study Group. Risperidone in the treatment of patients with chronic schizophrenia: A multi-national, multicentre, double-blind, parallel-group study versus haloperidol. Br J Psychiatry 1995;166:712-26.
    • (1995) Br J Psychiatry , vol.166 , pp. 712-726
    • Peuskens, J.1
  • 15
    • 0027443729 scopus 로고
    • Clinical review of risperidone
    • Chouinard G, Arnott W. Clinical review of risperidone. Am J Psychiatry 1993;38(Supl 3):S89-95.
    • (1993) Am J Psychiatry , vol.38 , Issue.3 SUPL
    • Chouinard, G.1    Arnott, W.2
  • 16
    • 0028342655 scopus 로고
    • Risperidone in the treatment of schizophrenia
    • Marder SR, Meibach RD. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994;151:825-35-
    • (1994) Am J Psychiatry , vol.151 , pp. 825-835
    • Marder, S.R.1    Meibach, R.D.2
  • 17
    • 0028339307 scopus 로고
    • Risperidone in schizophrenia
    • Editorial. Risperidone in schizophrenia. BMJ 1994; 308:1311-2.
    • (1994) BMJ , vol.308 , pp. 1311-1312
  • 18
    • 0027525137 scopus 로고
    • Clinical considerations in the use of risperidone
    • Remington G. Clinical considerations in the use of risperidone. Can J Psychiatry 1993;38(Supl 3):S96-100.
    • (1993) Can J Psychiatry , vol.38 , Issue.3 SUPL
    • Remington, G.1
  • 19
    • 0027958705 scopus 로고
    • Risperidone
    • Livington MG. Risperidone. Lancet 1994;343:457-60.
    • (1994) Lancet , vol.343 , pp. 457-460
    • Livington, M.G.1
  • 21
    • 0037593813 scopus 로고    scopus 로고
    • Trastornos por dependencia de sustancias psicotrópas
    • Cervilla JA, García-Ribera C. Barcelona: Masson;
    • Casas M, Prat G, Santís R. Trastornos por dependencia de sustancias psicotrópas. En: Cervilla JA, García-Ribera C. Fundamentos biológicos en psiquiatría. Barcelona: Masson; 2000. p. 269-81.
    • (2000) Fundamentos Biológicos en Psiquiatría , pp. 269-281
    • Casas, M.1    Prat, G.2    Santís, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.